Latest filing published 28 Feb 2012 for Aevi Genomic Medicine, LLC.
Insider track record
No signal scores available.
Gary A. Brukardt: trading record in brief
All filings by Gary A. Brukardt on record concern Aevi Genomic Medicine, LLC. In total, 5 filings cover trades dated from 24 May 2011 to 3 January 2012.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 28 February 2012: a share grant, in Aevi Genomic Medicine, LLC. Filings reach the SEC (Form 4) feed a median of 27 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary A. Brukardt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 shares0Common StockSEC:0001144204-12-011439:0
- 45,701 shares@ US$2.49Common StockSEC:0001144204-11-056266:0
- 29,504 shares@ US$3.86Common StockSEC:0001144204-11-056266:1
- 60,507 shares@ US$2.49Common StockSEC:0001144204-11-033617:0
- 42,238 shares@ US$3.57Common StockSEC:0001144204-11-033617:1
5 of 5 declarations